- Aktuelle Seite:
-
Home
- Substitution und Schwangerschaft
Maternal use of a combination of recreational and antiretroviral drugs (nyaope/whoonga): Case reports of their effects on the respiratory system in infants.
Mashiloane CP, Jeena PH, Thula SA, Singh SA, Masekela R.
Afr J Thorac Crit Care Med. 2021 Oct 4;27(3):10.7196/AJTCCM.2021.v27i3.112. doi: 10.7196/AJTCCM.2021.v27i3.112. PMID: 34761210; PMCID: PMC8573815.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573815/
Addiction curriculum design for medical students.
Hostetter K, Thakkar B, Edwards C, Martin CE.
Clin Teach. 2021 Nov 22. doi: 10.1111/tct.13438. Epub ahead of print. PMID: 34808694.
Abstract
https://pubmed.ncbi.nlm.nih.gov/34808694/
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy.
Meinhofer A, Hinde JM, Keyes KM, Lugo-Candelas C.
JAMA Psychiatry. Published online November 03, 2021. doi:10.1001/jamapsychiatry.2021.3193
Abstract
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2785860
Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study.
Badhan RKS, Gittins R.
J Subst Abuse Treat. 2021 Nov;130:108521. doi: 10.1016/j.jsat.2021.108521. Epub 2021 Jun 3. PMID: 34118695.
Abstract
https://pubmed.ncbi.nlm.nih.gov/34118695/
Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation.
Obstet Gynecol. 2017 Oct;130(4):e205-e209. doi: 10.1097/AOG.0000000000002354. PMID: 28937574.
https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/10/marijuana-use-during-pregnancy-and-lactation
Histological Changes Observed in Placentas Exposed to Medication-Assisted Treatment.
Staszewski C, Herrera KM, Kertowidjojo E, Ly V, Iovino N, Garretto D, Kaplan C, Persad MD, Garry DJ.
J Pregnancy. 2021 Oct 7;2021:2175026. doi: 10.1155/2021/2175026. PMID: 34659831; PMCID: PMC8516570.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516570/
Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care.
Epstein RL, Moloney C, Garfinkel J, Saia K, Wachman EM, Lodi S, Pelton SI. Enhancing
Hepatol Commun. 2021 Sep;5(9):1543-1554. doi: 10.1002/hep4.1748. Epub 2021 Jul 1. PMID: 34510828; PMCID: PMC8435278.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435278/
Smoking cessation interventions for pregnant women attending treatment for substance use disorders: A systematic review.
Jackson, MA, Baker, AL, Gould, GS, Brown, AL, Dunlop, AJ, McCarter, K.
Addiction. 2021; 1– 14. doi.org/10.1111/add.15663
https://onlinelibrary.wiley.com/doi/full/10.1111/add.15663
Integrated versus non-integrated treatment for perinatal opioid use disorder: Retrospective cohort study
Goodman, Dr. Daisy J. et al.
American Journal of Obstetrics & Gynecology MFM, Volume 0, Issue 0, 100489
https://www.ajogmfm.org/article/S2589-9333(21)00184-1/fulltext
"The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
Leiner C, Cody T, Mullins N, Ramage M, Ostrach BMM.
BMC Pregnancy Childbirth. 2021 Feb 17;21(1):143. doi: 10.1186/s12884-021-03596-w. PMID: 33596843; PMCID: PMC7890815.
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-021-03596-w
Puffy hand syndrome secondary to intravenous drug use presenting in pregnancy and persisting postpartum.
Gaghan LJ, Bode HP, Mervak JE.
JAAD Case Rep. 2021 Jul 10;14:124-126. doi: 10.1016/j.jdcr.2021.06.025. PMID: 34355053; PMCID: PMC8325063.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325063/
Barriers and Motivators to Opioid Treatment Among Suburban Women Who Are Pregnant and Mothers in Caregiver Roles.
Boeri M, Lamonica AK, Turner JM, Parker A, Murphy G, Boccone C.
Front Psychol. 2021 Jul 1;12:688429. doi: 10.3389/fpsyg.2021.688429. PMID: 34276513; PMCID: PMC8280285.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280285/
Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure.
Faherty LJ, Heins S, Kranz AM, Stein BD.
Womens Health Rep (New Rochelle). 2021 Jun 1;2(1):163-172. doi: 10.1089/whr.2020.0128. PMID: 34235503; PMCID: PMC8243701.
https://www.liebertpub.com/doi/10.1089/whr.2020.0128
Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic.
Singer LT, Chambers C, Coles C, Kable J.
Advers Resil Sci. 2020 Dec;1(4):223-234. doi: 10.1007/s42844-020-00021-7. Epub 2020 Oct 27. PMID: 34316723; PMCID: PMC8312986.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312986/
Pregnant Women with Substance Use Disorders — The Harm Associated with Punitive Approaches
Rebecca L. Haffajee, J.D., Ph.D., M.P.H., Laura J. Faherty, M.D., M.P.H., M.S.H.P., and Kara Zivin, Ph.D.
NEJM, June 19, 2021, DOI: 10.1056/NEJMp2101051, Free Preview
https://www.nejm.org/doi/full/10.1056/NEJMp2101051
Disparities in breastfeeding outcomes among women with opioid use disorder.
Stephen JM, Shrestha S, Yakes Jimenez E, Williams SM, Ortega A, Cano S, Leeman L, Bakhireva LN.
Acta Paediatr. 2020 May;109(5):1064-1066. doi: 10.1111/apa.15107. Epub 2019 Dec 9. PMID: 31762078; PMCID: PMC7174084.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174084/
Evidence for the Effectiveness and Acceptability of e-SBI or e-SBIRT in the Management of Alcohol and Illicit Substance Use in Pregnant and Post-partum Women.
Wouldes TA, Crawford A, Stevens S, Stasiak K.
Front Psychiatry. 2021 May 5;12:634805. doi: 10.3389/fpsyt.2021.634805. PMID: 34025470; PMCID: PMC8131659.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131659/
Facilitators and barriers to substance-free pregnancies in high-income countries: A meta-synthesis of qualitative research.
Escañuela Sánchez T, Matvienko-Sikar K, Linehan L, O'Donoghue K, Byrne M, Meaney S.
Women Birth. 2021 Apr 29:S1871-5192(21)00076-7. doi: 10.1016/j.wombi.2021.04.010. Epub ahead of print. PMID: 33935004.
https://www.sciencedirect.com/science/article/pii/S1871519221000767
Infant Mortality Associated With Prenatal Opioid Exposure.
Leyenaar JK, Schaefer AP, Wasserman JR, Moen EL, O’Malley AJ, Goodman DC.
JAMA Pediatr. Published online April 12, 2021. doi:10.1001/jamapediatrics.2020.6364
Abstract
https://jamanetwork.com/journals/jamapediatrics/article-abstract/2778433
Post-Cesarean Delivery Analgesic Outcomes in Patients Maintained on Methadone and Buprenorphine: A Retrospective Investigation.
Reno JL, Kushelev M, Coffman JH, Prasad MR, Meyer AM, Carpenter KM, Palettas MS, Coffman JC.
J Pain Res. 2020 Dec 30;13:3513-3524. doi: 10.2147/JPR.S284874. PMID: 33408510; PMCID: PMC7779306.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779306/
Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study
Bateman Brian T, Hernandez-Diaz Sonia, StraubLoreen, Zhu Yanmin, Gray Kathryn J, Desai Rishi Jet al.
BMJ 2021; 372 :n102
https://www.bmj.com/content/372/bmj.n102
BAS. Behandlung substituierter Frauen während Schwangerschaft und Geburt
Ein Informationspapier für Ärztinnen und Ärzte aus der Geburtshilfe und Pädiatrie sowie Hebammen
Erbas B, Huber G und Wolstein J (Stand November 2020) - Bayerische Akademie für Sucht- und Gesundheitsfragen
https://www.bas-muenchen.de/fileadmin/documents/pdf/Publikationen/Papiere/BAS_UG_Informationspapier_Behandlung_substituierter_Schwangerer_Nov_2020.pdf
Barriers to accessing opioid agonist therapy in pregnancy.
Bedrick BS, O'Donnell C, Marx CM, Friedman H, Carter EB, Stout MJ, Kelly JC.
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100225. doi: 10.1016/j.ajogmf.2020.100225. Epub 2020 Sep 15. PMID: 33345932.
https://www.ajogmfm.org/article/S2589-9333(20)30193-2/fulltext
Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.
Link HM, Jones H, Miller L, Kaltenbach K, Seligman N.
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100179. doi: 10.1016/j.ajogmf.2020.100179. Epub 2020 Jul 3. PMID: 33345863.
https://www.ajogmfm.org/article/S2589-9333(20)30123-3/fulltext
Medication-assisted treatment vs. detoxification for women who misuse opioids in pregnancy: Associations with dropout, relapse, neonatal opioid withdrawal syndrome (NOWS), and childhood sexual abuse.
Macfie J, Towers CV, Fortner KB, Stuart GL, Zvara BJ, Kurdziel-Adams G, Kors SB, Noose SK, Gorrondona AM, Cohen CT.
Addict Behav Rep. 2020 Nov 12;12:100315. doi: 10.1016/j.abrep.2020.100315. PMID: 33364323; PMCID: PMC7752716.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752716/
Use of Injectable Opioid Agonist Therapy in a In-Patient Setting for a Pregnant Patient With Opioid Use Disorder: A Case Report.
Griffiths S, Campbell DM, Caudarella A, Guimond T, Lamba W, Lurie E, Nader M, Sgro M, Turner S.
J Addict Med. 2020 Nov 23. doi: 10.1097/ADM.0000000000000776. Epub ahead of print. PMID: 33234803.
Abstract
https://pubmed.ncbi.nlm.nih.gov/33234803/
Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, Davoli M.
Cochrane Database Syst Rev. 2020 Nov 9;11:CD006318. doi: 10.1002/14651858.CD006318.pub4. PMID: 33165953.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006318.pub4/full
Pregnancy and Substance Use – A Harm Reduction Toolkit
NATIONAL HARM REDUCTION COALITION in Collaboration with Academy of Perinatal Harm Reduction
http://fileserver.idpc.net/library/Preg_Subst_Use_Harm_Reduction_Toolkit.pdf
Changing Outdated Methadone Regulations That Harm Pregnant Patients
McCarthy JJ, Jones HE, Terplan M, Rudolf VP, von Klimo MC.
[published online ahead of print, 2020 Aug 18]. J Addict Med. 2020;10.1097/ADM.0000000000000720. doi:10.1097/ADM.0000000000000720
Abstract
https://pubmed.ncbi.nlm.nih.gov/32826620/
Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.
Patrick SW, Richards MR, Dupont WD, et al.
JAMA Netw Open. 2020;3(8):e2013456. Published 2020 Aug 3. doi:10.1001/jamanetworkopen.2020.13456
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428808/
Seite 1 von 6